This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Report Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The analyst’s summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Maruho Co Ltd (Maruho) is a pharmaceutical company that researches, develops, produces, and distributes dermatological products. Its product portfolio includes an array of prescription drugs, medical devices and other skincare products. The company also offers products for the treatment of infectious diseases, ophthalmological diseases, ear, nose, throat disorders, musculoskeletal disorders, central nervous system (CNS) disorders, and cardiovascular, gastrointestinal, and other diseases. Maruho offers prescription drugs in various forms such as ointments, creams, solutions, lotions, injections, and gels. The company has manufacturing facilities in Germany, Japan and the US. Maruho is headquartered in Osaka, Japan.Maruho Co Ltd Key Recent Developments
- Jan 22, 2026: Maruho Signs Licensing Agreement to Export Hyperhidrosis Treatment to Taiwan
- Nov 04, 2025: License Agreement for Common Warts Treatment Drug in Asia
- Oct 09, 2025: Licensing Agreement for Varicella-Zoster Virus Antigen Kit Export to ASEAN
- Sep 30, 2025: Conclusion Of Investment Agreement With Sibel Health, Inc
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Noevir Holdings Co Ltd
- Lee's Pharmaceutical Holdings Ltd
- Rohto Pharmaceutical Co Ltd
- Toyo Shinyaku Co Ltd
- Pola Pharma Inc

